Therapeutics

Technologies:

  • Ets2 and Mesp1 generate cardiac progenitors from fibroblasts
  • ETS2 AND MESP1 GENERATE CARDIAC PROGENITORS FROM FIBROBLASTS
  • MicroRNA-130a,b as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
  • MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
  • Cocrystalline DHEA Formulations
  • SYSTEM AND METHOD FOR ULTRASOUND IDENTIFICATION AND MANIPULATION OF MOLECULAR INTERACTIONS
  • Compositions, Methods and Kits for Treating a Contact Lens
  • SYSTEMS AND METHODS FOR ESTIMATING A NERVOUS SYSTEM STATE BASED ON MEASUREMENT OF A PHYSIOLOGICAL CONDITION
  • COCRYSTALLINE DHEA FORMULATIONS
  • A method for molecular extraction in live cells
  • Steroid-Sparing Effects of Beta-Adrenergic Inverse Agonists and Uses Thereof
  • THERAPEUTIC MIRNAS FOR TREATING HEART AND SKELETAL MUSCLE DISEASES
  • Therapeutic MiRNAs for Treating Heart and Skeletal Muscle Diseases
  • Nanoporous Gold and Silver Nanoparticles and Substrates for Molecular and Biomolecular Sensing
  • Ets2 and mesp1 generate cardiac progenitors from fibroblasts
  • Fructose-1,6-biphosphatases as new targets for diagnosing and treating breast cancer brain metastasis
  • Locally Bioavailable Drugs
  • TARGETED DELIVERY OF ACTIVE AGENTS USING THERMALLY STIMULATED LARGE INCREASE OF PERFUSION BY HIGH INTENSITY FOCUSED ULTRASOUND
  • Small Molecule Liver X Receptor Modulators and Uses Thereof
  • INHIBITORS OF IL-15 AND THEIR USE IN TREATING AUTOIMMUNE/INFLAMMATORY DISORDERS
  • PEPTOID COMPOUNDS THAT BIND TO CELL RECEPTOR ACE2 AND PREVENT VIRUS ENTRY INTO CELLS
  • NOVEL PEPTOID COMPOUNDS THAT BIND TO CELL RECEPTOR ACE2 AND PREVENT VIRUS ENTRY INTO CELLS
  • SYSTEM AND METHOD FOR PREDICTING BLOOD-GLUCOSE CONCENTRATION
  • Compositions and Methods of Treatment of Muscle Disorders by Targeting H19X-Encoded Non-Coding RNAs
  • Discovery and use of immunogenic peptides for the treatment and prevention of cancers
  • A Small Molecule that in vitro Neutralizes Infection of SARS-CoV-2 and its most Infectious Variants, Delta and Omicron
  • Discovery and Use of Immunogenic Peptides for the Treatment and Prevention of Cancers
  • HEADSET APPARATUS
  • SMALL MOLECULES THAT TREAT OR PREVENT VIRAL INFECTIONS
  • Downregulation of Rhodopsin as a Therapeutic Strategy for Peripherin-2-Associated Inherited Retinal Disorders
  • PEPTOID COMPOSITIONS TARGETING RAS PROTEINS AND METHODS OF TREATMENT OF CANCER USING THE SAME
  • Sensorized Bead-Wire Toy for Studying Finger Force and Manual Dexterity
  • ENGINEERING NON-CYTOTOXIC DELIVERY OF PROTEINS BY T-CELLS VIA FUSION TO NPC2
  • COMBINATION THERAPY FOR SUBSTANCE USE DISORDERS
  • INHIBITORS OF IL-15 AND THEIR USE IN TREATING OR PREVENTING SEPSIS, SEVERE SEPSIS AND SEPTIC SHOCK
  • Vimentin Targeted Peptoids for Early Diagnosis and Treatment of Cancer
  • DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS
  • mRNA VACCINE FOR HERPES SIMPLEX VIRUS